Purchases and Sales Made in Q2 2023 in Arcus Biosciences, Inc. (RCUS)
This table provides information about the institutional ownership of Arcus Biosciences, Inc. (RCUS) during Q2 2023. The information is specifically focused on institutions that hold shares of Arcus Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-460K- 85.22% |
$7.81M - $10.1M
|
79.8K
$955K
|
|
|
Aug 10, 2023
Q2 2023
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-650K- 50.61% |
$11M - $14.3M
|
634K
$7.59M
|
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-667K- 6.58% |
$11.3M - $14.7M
|
9.47M
$113M
|
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-961K- 83.64% |
$16.3M - $21.2M
|
188K
$2.25M
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.03M- 58.35% |
$17.5M - $22.7M
|
736K
$8.81M
|
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.15M- 21.0% |
$19.6M - $25.4M
|
4.34M
$52M
|